michael eccles
University of Otago
Dunedin, New Zealand
Associate Editor
Cancer Genetics
University of Otago
Dunedin, New Zealand
Associate Editor
Cancer Genetics
Medical University of Vienna
Vienna, Austria
Associate Editor
Neuro-Oncology and Neurosurgical Oncology
Vanderbilt Vaccine Center, Vanderbilt University Medical Center
Nashville, United States
Associate Editor
Neuro-Oncology and Neurosurgical Oncology
International Centre for Genetic Engineering and Biotechnology
Trieste, Italy
Associate Editor
Hematologic Malignancies
German Cancer Research Center (DKFZ)
Heidelberg, Germany
Associate Editor
Cancer Immunity and Immunotherapy
British Columbia Cancer Agency
Vancouver, Canada
Associate Editor
Genitourinary Oncology
Jove Hospital Foundation
GijĂłn, Spain
Associate Editor
Molecular and Cellular Oncology
Michigan Medicine, University of Michigan
Ann Arbor, United States
Associate Editor
Head and Neck Cancer
University of Texas MD Anderson Cancer Center
Houston, United States
Associate Editor
Cancer Immunity and Immunotherapy
Department of Immunology, Moffitt Cancer Center
Tampa, United States
Associate Editor
Cancer Immunity and Immunotherapy
Institute for Cancer Research, Oslo University Hospital
Oslo, Norway
Associate Editor
Cancer Genetics
American University of Beirut Medical Center
Beirut, Lebanon
Associate Editor
Hematologic Malignancies
Faculty of Veterinary Medicine, Kafrelsheikh University
Kafrelsheikh, Egypt
Associate Editor
Pharmacology of Anti-Cancer Drugs
Faculty of Pharmacy, Kafrelsheikh University
Kafrelsheikh, Egypt
Associate Editor
Pharmacology of Anti-Cancer Drugs
SĂŁo Paulo State University
SĂŁo Paulo, Brazil
Associate Editor
Molecular and Cellular Oncology
Faculty of Health Sciences, Ben-Gurion University of the Negev
Beer Sheva, Israel
Associate Editor
Molecular and Cellular Oncology